Literature DB >> 18842210

[Quality of life specific questionnaire for constipated patients: development and validation of CVE-20].

Mónica Perona1, Fermín Mearin, Magda Guilera, Miguel Mínguez, Vicente Ortiz, Miguel Montoro, Jordi Serra, Carlos Casanova, Enrique Rey, Onofre Alarcón, Luis Bujanda, Antonio Lima, Montse Andreu, Manuel Castro, Antonio López, Ricardo Carrillo, Laura Sempere, Xavier Badia.   

Abstract

BACKGROUND AND
OBJECTIVE: Although constipation affects quality of life, questionnaires hardly exist for its evaluation. We aimed to develop and validate a questionnaire able to measure the quality of life in patients with constipation. PATIENTS AND
METHOD: A Spanish multicenter study was performed in 2 stages: a) questionnaire development (open interview to patients with constipation, pilot questionnaire, quantitative and factorial analysis, Rasch analysis, and specific questionnaire design), and b) questionnaire validation in 136 patients. These patients were divided in 2 groups: a) reliability group (n = 55; no need to begin or change treatment; re-tested after 15 days), and b) sensibility to change group (n = 81; need to begin or change treatment; re-tested after 3 months). We collected clinical and socio-demographic data and we evaluated the quality of life through the general questionnaire EuroQoL-5D (EQ-5D) and the specific one, design in the previous stage (25 items). After that, we analysed feasibility, reliability and validity (of content, convergent and longitudinal).
RESULTS: The trial questionnaire was obtained during the development stage and the results were 51 items that were later reduced to 25 in the validation stage. A total of 126 patients (93% women; mean age [standard deviation]: 43.4 [1] years) completed the study properly. The answer average time was 12 min. The content validity process reduced the questionnaire to 20 items (CVE-20) within 4 domains: emotional, general physical, rectal physical and social. The reliability was good in relation to the general punctuation (Cronbach alpha coefficient = 0.87), being in the different domains of 0.79, 0.73, 0.75 and 0.60, respectively. The construct validity showed a good correlation between the CVE-20 results and constipation severity. The CVE-20 score positively correlated with EQ -5D changes. The test and re-test reliability were good: interclass correlation coefficient = 0.89 (ranging from 0.80 to 0.88 in the different domains). The clinically relevant and minimal difference was 17 points (95% confidence interval, 11-23). The content validity showed a strong correlation between CVE-20 and constipation severity.
CONCLUSIONS: The CVE-20 is the first specific questionnaire in Spanish language for constipated patients; it is valid, reliable, sensitive to changes and it meets the psychometric requirements to be applied in daily practice and clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18842210     DOI: 10.1016/s0025-7753(08)72285-1

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  2 in total

Review 1.  Epidemiology and burden of chronic constipation.

Authors:  Maria Ines Pinto Sanchez; Premysl Bercik
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

2.  Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms.

Authors:  Blanca Serrano-Falcón; Sílvia Delgado-Aros; Fermín Mearin; Constanza Ciriza de Los Ríos; Jordi Serra; Miguel Mínguez; Miguel Montoro Huguet; Antonia Perelló; Cecilio Santander; Ángeles Pérez Aisa; Inmaculada Bañón-Rodríguez; Enrique Rey
Journal:  Therap Adv Gastroenterol       Date:  2019-08-05       Impact factor: 4.409

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.